News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|October 25, 2018

6 Reports That Shine a Light on Stress and Trauma

Author(s)Lori Davis, MD

This collection brings together topics on trauma and stress that are neglected in the current literature.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Investigational Psilocybin for PTSD and Ongoing Trials

Investigational Psilocybin for PTSD and Ongoing Trials

ByGary W. Small, MD

February 5th 2026

anxiety negative allosteric modulator

Data Supports Potential of Negative Allosteric Modulators for Anxiety and Fear-Related Disorders

ByJessica Walters

February 4th 2026

violence against doctor

Violence in Psychiatry: Stop Pretending It’s Just “Part of the Job”

ByGarrett Rossi, MD

January 20th 2026

depression

Lifestyle Psychiatry for Supporting Individuals With Major Depressive Disorder

BySam Manger, MD,Wolf Marx, PhD

January 19th 2026

FDA Accepts Investigational New Drug Application for COMP360 for PTSD

ByHeidi Anne Duerr, MPH

January 7th 2026

Latest CME

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

OCD, Psychedelics, and Cannabinoids: New Evidence

Glutamate and GABA: The Yin and Yang of the Human Brain

From Practice to Purpose: Cultivating Leadership in Psychiatry

Lisdexamfetamine Dimesylate Oral Solution for ADHD to Be Available Mid-2026

Buntanetap for Neurodegenerative Diseases: Positive Recommendation From Data and Safety Monitoring Board